retatrutide clinical trials phase 2 Eli Lilly infiltrates anti-obesity market as III trial for begins Phase 2 Trial

GLP-1 is the hormone responsible for inhibiting the production of glucagon and promoting the production of insulin

This is a large, carefully designed observational study not a randomised trial so it points to a promising signal rather than a proven benefit

- Neuroprotection: Alzheimers, Parkinsons by reducing Amyloid-beta formation by decreasing neuro inflammation and oxidative stress

Its unique role in the brain-gut axis supports both gut health and neuroprotection, influencing neurotransmitter balance and nerve regeneration, making it relevant for inflammatory disorders, injuries, and neurodegenerative diseases

Prenatal maternal low selenium, high thyrotropin, and low birth weights